Helicobacter pylori is a Gram-negative bacterium that colonizes the human stomach. H. pylori infection is associated with an increased risk of cancer of the distal stomach and peptic ulcer disease. In previous studies, we have conducted detailed analyses of a secreted H. pylori toxin (VacA). The H. pylori genome contains three genes that are distantly related to vacA, and each encodes a protein >250 kDa in size. Similar to VacA, these VacA-like proteins are predicted to be secreted by a type V (autotransporter pathway). Bacterial proteins that are secreted by autotransporter pathways typically have important roles in the pathogenesis of infectious diseases. In contrast to VacA, which has been studied in great detail, thus far there has been very little study of H. pylori VacA-like proteins. Recent studies provide evidence that one of the VacA-like proteins (FaaA) localizes to flagella and has a role in H. pylori motility, and another VacA-like protein (ImaA) has anti-inflammatory activity. Hypotheses: The overarching hypotheses of this proposal are as follows: (i) the transcription of VacA-like proteins is tightly regulated in response to multiple stimuli, thereby allowing orchestrated expression of these in a manner that optimizes H. pylori colonization of the human stomach, and (ii) each of the VacA-like proteins has a specialized function designed to enhance H. pylori colonization of the stomach. Study Objectives: The long-term goals of this work are to understand the molecular mechanisms that allow H. pylori to colonize and persist in the human gastric mucosa, to understand the molecular mechanisms by which H. pylori infection leads to the development of gastric cancer or peptic ulcer disease, and to develop effective strategies for the prevention of gastric cancer and peptic ulcer disease. The specific objectives are (i) to define the mechanisms by which faaA and imaA are regulated; (ii) to define the roles of FaaA and ImaA in H. pylori colonization of the stomach and H. pylori-induced gastric disease; and (iii) to define mechanisms by which ImaA modulates H. pylori-induced inflammatory responses. Methods: To investigate the regulation of faaA and imaA expression, we will undertake in-depth studies of the promoter regions of these genes and identify regulatory systems that are responsible for the observed regulation of gene expression. We will investigate the roles of FaaA and ImaA in vivo through use of a system that allows expression of these proteins under control of an inducible promoter. Finally, we will use multiple approaches to investigate how the presence or absence of ImaA influences multiple phenotypes, including assembly of the cag type IV secretion system.

Public Health Relevance

Helicobacter pylori infection is common among Veterans, and Veterans are at risk for development of H. pylori-induced diseases such as stomach cancer and peptic ulcers. During travel to various parts of the world, Veterans are at risk for acquiring H. pylori strains that coner a relatively higher risk of gastric cancer compared to strains found in the United States. The Veterans Administration currently spends millions of dollars each year for acid-suppressive drug regimens to prevent H. pylori-induced complications. Investigation of the molecular mechanisms by which H. pylori colonizes the human stomach and causes gastric diseases is likely to lead to the development of new approaches for the prevention and treatment of H. pylori infection, which would have important clinical implications for the care of Veterans.

Agency
National Institute of Health (NIH)
Institute
Veterans Affairs (VA)
Type
Non-HHS Research Projects (I01)
Project #
5I01BX000627-08
Application #
9486830
Study Section
Infectious Diseases B (INFB)
Project Start
2009-10-01
Project End
2018-09-30
Budget Start
2017-10-01
Budget End
2018-09-30
Support Year
8
Fiscal Year
2018
Total Cost
Indirect Cost
Name
Veterans Health Administration
Department
Type
DUNS #
156385783
City
Nashville
State
TN
Country
United States
Zip Code
37212
Kyburz, A; Urban, S; Altobelli, A et al. (2017) Helicobacter pylori and its secreted immunomodulator VacA protect against anaphylaxis in experimental models of food allergy. Clin Exp Allergy 47:1331-1341
Feichtinger, René G; Neureiter, Daniel; Skaria, Tom et al. (2017) Oxidative Phosphorylation System in Gastric Carcinomas and Gastritis. Oxid Med Cell Longev 2017:1320241
McClain, Mark S; Beckett, Amber C; Cover, Timothy L (2017) Helicobacter pylori Vacuolating Toxin and Gastric Cancer. Toxins (Basel) 9:
Beckett, Amber C; Piazuelo, M Blanca; Noto, Jennifer M et al. (2016) Dietary Composition Influences Incidence of Helicobacter pylori-Induced Iron Deficiency Anemia and Gastric Ulceration. Infect Immun 84:3338-3349
Snider, Christina A; Voss, Bradley J; McDonald, W Hayes et al. (2016) Growth phase-dependent composition of the Helicobacter pylori exoproteome. J Proteomics 130:94-107
Foegeding, Nora J; Caston, Rhonda R; McClain, Mark S et al. (2016) An Overview of Helicobacter pylori VacA Toxin Biology. Toxins (Basel) 8:
Shaffer, Carrie L; Good, James A D; Kumar, Santosh et al. (2016) Peptidomimetic Small Molecules Disrupt Type IV Secretion System Activity in Diverse Bacterial Pathogens. MBio 7:e00221-16
Pyburn, Tasia M; Foegeding, Nora J; González-Rivera, Christian et al. (2016) Structural organization of membrane-inserted hexamers formed by Helicobacter pylori VacA toxin. Mol Microbiol 102:22-36
Cover, Timothy L (2016) Helicobacter pylori Diversity and Gastric Cancer Risk. MBio 7:e01869-15
Frick-Cheng, Arwen E; Pyburn, Tasia M; Voss, Bradley J et al. (2016) Molecular and Structural Analysis of the Helicobacter pylori cag Type IV Secretion System Core Complex. MBio 7:e02001-15

Showing the most recent 10 out of 20 publications